Chemicals classified as ASB-9 Inhibitors are not inhibitors in the traditional sense where a chemical compound directly binds to and inhibits a protein. Instead, these are chemicals that may indirectly impact the ankyrin repeat and SOCS box containing 9 (ASB-9) protein by modulating related signaling pathways or cellular processes. Since ASB-9 is part of a protein complex that is involved in the ubiquitination and subsequent proteasomal degradation of target proteins, inhibitors of proteasome function can indirectly affect the functional activity of ASB-9 by preventing the degradation of proteins that ASB-9 may target for ubiquitination.
Furthermore, the function of ASB-9 may also be influenced by changes in cellular signaling cascades. Certain compounds inhibit various kinases and signaling molecules like NF-κB, STAT3, JNK, PI3K, p38 MAPK, and MEK. By modulating these signaling pathways, these compounds can exert an indirect influence on the cellular processes in which ASB-9 is involved, such as protein-protein interactions and metabolic pathways. The exact influence of these compounds on ASB-9's activity depends on the cellular context and the interplay between the aforementioned signaling pathways and the ubiquitin-proteasome system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Interferes with NF-κB signaling, which may modulate the degradation process of proteins involving SOCS box proteins like ASB-9. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibitor of STAT3, potentially altering SOCS protein-mediated processes, impacting ASB-9 function indirectly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, may affect downstream effects of ASB-9 by altering JNK-related signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, may affect pathways that indirectly modulate ASB-9's role in protein turnover. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, could alter cell signaling pathways involving ASB-9. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, which may affect signaling pathways ASB-9 is involved in. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, could affect the degradation of proteins that ASB-9 targets. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Specific inhibitor of the proteasome, affecting protein degradation pathways that ASB-9 may be part of. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, could impact ASB-9's role in protein degradation. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Selective proteasome inhibitor, affects protein degradation and could influence ASB-9 activity. | ||||||